The epidermal growth factor receptor (EGFR) and human epidermal receptor (HER-2) protein tyrosine kinase are important protein targets for anti-tumor drug discovery to identify potential EGFR and HER-2 inhibitors, we conducted 2D and 3D Quantitative structure-activity relationship (QSAR) studies on the inhibitory activity of recently synthesized pyrazolyl-thiazolinone derivatives (E1-E36) and from best model predicted activity of novel pyrazolyl-thiazolinone derivatives. 2D and 3D QSAR study was performed by using multiple linear regression method and KNN MFA method respectively by using random selection and manual data selection of 36 compound (E1-E36). The statistically best 2D QSAR model (r 
Introduction
The epidermal growth factor (EGFR) and Human epidermal receptor HER-2, belonging to the family of Receptor tyrosine kinase (RTKs) also called as phosphotyrosine kinase. Receptor tyrosine kinase are single pass transmembrane protein important in intercellular signaling, by translating extracellular signals (ligands or growth factors) into activation of specific cell signaling cascades [2, 3] that is they plays an important role in signal transduction pathways that regulate cell division and differentiation. The receptor tyrosine kinase family comprises of four members: EGFR (HER-1/ErbB-1), HER-2 (ErbB-2), HER-3 (ErbB-3) and HER-4 (ErbB-4). [4] *Corresponding author. E-mail address: pharmacy_2003@rediffmail.com (Anwar R. Shaikh) 2230-7842 / © 2015 JCPR. All rights reserved.
EGFR, a transmembrane protein tyrosine kinase that is activated by ligand induced dimerization, plays a critical role in regulating cell proliferation, differentiation and migration [5] . The Human epidermal growth factor 2 (HER-2) is localized is to chromosome 17q and encodes transmembrane tyrosine kinase receptor protein. [1] A large body of experimental and clinical work to support the view that the EGFR is a relevant target for cancer therapy. Two therapeutic approaches have been shown most promising and are currently being used to inhibit the EGFR: (a) MAbs; and (b) small molecule inhibitors of the EGFR tyrosine kinase enzymatic activity. Maps are generally directed at the external domain of the EGFR to block ligand binding and receptor activation. TKIs prevent the autophosphorylation of the intracellular tyrosine kinase domain of the EGFR.
EGFR tyrosine kinase-mediate cell growth signaling pathways plays an important role in the formation and development of many types of solid tumors, including head and neck, lung, breast, bladder, prostate and kidney cancers. [6] [7] [8] [9] Therefore, EGFR tyrosine kinase represents an attractive target for the development of novel anticancer agents. EGFR and HER-2 are the hottest targets in current cancer research and their over expression or abnormal activation often cause cell malignant transformation. Gefitinib and Erlotinib are the representative drugs for this kind of inhibitors and have been approved by US FDA for the treatment of patient with non small-cell-lung cancer (NSCLC). [10, 11] Thiazolinone and their derivative have attracted continuing interest over the years because of their varied biological activities, such as anti-inflammatory, antimicrobial, antiproliferative, antiviral, anticonvulsant, antifungal and antibacterial. [12, 13] Recent years thiazolinone derivative with their antitumor activity have become popular. Havrylyuk et al. reported that thiazolinones containing benzothiazole moiety has anticancer activity on leukemia, lung, colon, CNS, ovarian, renal, prostate and breast cancers cell lines. [14] The pyrazole motif makes up the core structure of numerous biologically active like antiviral/antitumor, antibacterial, antiinflammatory analgesic, fungistatic and anti hypoglycemic activity. [15] Pyrazole derivative containing thiourea skeleton were recently reported as potent anticancer agents targeting EGFR. The pyrazole ring along with the thiazolinone ring the two combined substructure might exhibit synergistic anticancer effect. By integrating these two heterocyclic rings we can synthesize some novel pyrazolyl-thiazolinone derivative as a potential EGFR and HER-2 inhibitory agent. Quantitative structure-activity relationship (QSAR) is the most popular theoretical method for modeling a compound's biological activity of its chemical structure. [16] [17] [18] Using this approach, scientists could predict the activities of a series of newly designed drugs before making the final decision on whether or not to synthesize and assay them. The prediction is based on the structural descriptors of the molecular features that most accounts for the variations in biological activity. Furthermore, this method also can identify and describe the most important structural features of the compounds which are relevant to the variations in molecular properties, thus, it also gains an insight into the structural factors which affect the molecular properties. QSAR models of EGFR inhibitors have been recently investigated with encouraging results. [19] [20] [21] [22] Four QSAR models were constructed from a set of known pyrazolyl-thiazolinone derivatives EGFR and HER-2 inhibitors with multiple linear regression method and kNN MFA method by using random and manual data selection (training and test set). The study sheds the light on the structure-activity relationship of this class of EGFR and HER-2 inhibitors and has the potential predicted ability to identify new EGFR and HER-2 inhibitors. From these four best 2D and 3D QSAR models pIC 50 value was predicted of newly drawn 20 pyrazolythiazolinone derivatives structure and conforming that structure by Chem spider. The pIC 50 value of these newly designed inhibitors was found to be higher or equal to that of already synthesized inhibitors [E1-E36]. All Docking studies and conformational analysis were performed using the Molecular Design Suite (VLife MDS software package, version 4.2.). The application of computational methods to study the formation of intermolecular complexes is a subject of intensive research. The drug exerts its biological activity by binding to the pocket of receptor molecule (usually protein). In their binding conformations, the molecules exhibit geometric and chemical complementarily, both of which are essential for successful drug activity. The computational process of searching for a ligand that is able to fit both geometrically and energetically into the binding site of a protein is called molecular docking. Molecular docking helps in studying drug/ ligand or receptor/ protein interactions by identifying the suitable active sites in protein, obtaining the best geometry of ligandreceptor complex and calculating the energy of interaction for different ligands to design more effective ligands. 
Materials and Methods

QSAR studies Selection of molecules
A data set of 36 pyrazolyl-thiazolinone derivatives ( (Table 2) . Molecules were rationally divided into the training set and test set by random and manual selection method.
Molecular modeling:
All computational experiments were performed using on HCL computer having genuine Intel Pentium Dual Core Processor and Windows XP operating system using the software Molecular Design Suite (vlifeMDS 4.2.). Structures were drawn using the 2D draw application and converted to 3D structures and subjected to an energy minimization and geometry optimization using Merck Molecular Force Field, force field minimization and charges followed by Austin Model-1 with 10000 as the maximum number of cycles, 0.01 as convergence criteria (root mean square gradient) and 1.0 as constant (medium's dielectric constant which is 1) in dielectric properties. The default values of 30.0 and 10.0 Kcal/mol were used for electrostatic and steric energy cutoff.
2D-QSAR analysis Calculation of descriptors
The number of descriptors were calculated after optimization or minimization of the energy of the data set molecules. 
Generation of training and test sets:
In order to evaluate the QSAR model, the data set was divided into training and test set using random selection and manual selection method. The training set is used to develop the QSAR model for which biological activity data are known. The test set is used to challenge the QSAR model developed based on the training set to assess the predictive power of the model which is not included in model generation.
Random Selection Method:
In order to construct and validate the QSAR models, both internally and externally, the data sets were divided into training [90%-60% (90%, 85%, 80%, 75%, 70%, 65% and 60%) of the total data set] and test sets [10%-40% (10%, 15%, 20%, 30%, 35% and 40%) of the total data set] in a random manner. 10 trials were run in each case.
Manual data selection method:
The data set is divided manually into training and test sets on the basis of the result obtained by the random selection method.
Generation of 2D-QSAR models:
Multiple linear regression method is used for 2D analysis. Multiple regression is the standard method for multivariate data analysis. It is also called as ordinary least squares regression (OLS). This method of regression estimates the values of the regression coefficients by applying least squares curve fitting method. For getting reliable results, dataset having typically 5 times as many data points (molecules) as independent variables (descriptors) is required. The regression equation takes the form Y = b1*x1 + b2*x2 + b3*x3 + c, Where, Y is the dependent variable, the 'b' is regression coefficients for corresponding 'x' is independent variable, 'c' is a regression constant or intercept.
Stepwise multiple regression (SMR)
It is an approach to select a subset of variables, when the numbers of independent variables (descriptors) are much more than the number of data points (molecules). It is also a procedure to examine the impact of each variable to the model step by step. Each variable is added to the equation and a new regression is performed. The variable that cannot contribute much to the variance explained would not be added. As a result, SMR generates a single, multiple regression equation. 3D-QSAR analysis: kNN-MFA kNN-MFA is novel methodology, unlike conventional QSAR regression methods; this methodology can handle nonlinear relationships of molecular field descriptors with biological activity, thus making it a more accurate predictor of biological activity. The standard kNN method is implemented simply as follows: (i) calculate distances between an unknown object (u) and all the objects in the training set; (ii) select k objects from the training set most similar to object u, according to the calculated distances, (iii) classify object u with the group to which a majority of the k objects belongs. An optimal k value is selected by the optimization through the classification of a test set of samples or by the leave-one out cross-validation. The variables and optimal k values are chosen using different variable selection methods as described below. kNN-MFA with Simulated Annealing Simulated Annealing (SA) is another stochastic method for function optimization employed in QSAR. Simulated annealing (SA) is the simulation of a physical process, 'annealing', which involves heating the system to a high temperature and then gradually cooling it down to a preset temperature (e.g., room temperature). During this process, the system samples possible configurations distributed according to the Boltzmann distribution, so that at equilibrium, low energy states are the most populated. kNN-MFA with Stepwise (SW) Variable Selection. This method employs a stepwise variable selection procedure combined with kNN to optimize the number of nearest neighbors (k) and the selection of variables from the original pool as described in simulated annealing Alignment rules: Molecular alignment was used to visualize the structural diversity in the given set of molecules. This was followed by generation of common rectangular grid around the molecules. The template structure, i.e. unsubstituted pyrazolyl-thiazolinone was used for alignment by considering the common elements of the series as shown in Figure 2 . The reference molecule 28 is chosen high inhibitory effect which made it a valid lead molecule and therefore was chosen as a reference molecule. After optimizing, the template structure and the reference molecule were used to superimpose all molecules from the series using the template alignment method. kNN-MFA method requires suitable alignment of given set of molecules after optimization; alignment was carried out by template based alignment method.
Fig.2. Para substituted pyrazolyl thiazolinone derivatives (template structure) Creation of interaction energies
Methyl probe with charge 1 and energy cut-off for electrostatic 10 Kcal/mol and for steric 30 Kcal/mol, dielectric constant 1 and charge type Gasteiger-marsili were used to calculate steric and electrostatic fields. The fields were computed at each lattice intersection of a regularly spaced grid of 2.0 A° within a defined three-dimensional region.
Generation of training and test sets
In order to evaluate the QSAR model, the data set was divided into training and test set using random selection and Manual selection method. The training set is used to develop the QSAR model for which biological activity data are known. The test set is used to challenge the QSAR model developed based on the training set to assess the predictive power of the model which is not included in model generation. Docking studies on para-substituted pyrazolyl-thiazolinone derivativeAll Docking studies and conformational analysis were performed using the Molecular Design Suite (VLife MDS software package, version 4.2; from VLife Sciences, Pune, India). 2D structure was drawn by Vlife2Ddraw and converted to 3D. Then this 3D structure is optimized and conformers were generated (Monte Carlo method) and least energy conformers were selected. For preparation of ligand perform the geometry minimization of the ligand. 
Results and discussion
QSAR: 2D QSAR:
In 2D QSAR analysis, Multiple linear regression analysis (MLR) coupled with stepwise forward, backward variable selection method was applied to generate 2D models. Selection of training and test set was done by Manual data selection, Random selection method. From these models, the one having good q 2 and pred_r 2 values was selected as the best model. Statistically significant 2D QSAR models are shown in Table 3 Fig. 3 , it reveals that the descriptors prediction and T_2_O_7 contributing 27.92% and 22.036% respectively, and other descriptors T_2_Cl_5, Quadrapole 1 and Mom Inertia is contributing inversely 9.284%, 29.67% and 11.076% respectively to biological activity. Data fitness plot for model 1 is shown in Fig.3 Fig.5 , the plot of observed vs. The predicted activity provides an idea about how well the model was trained and how well it predicts the activity of an external test set. The graph of actual vs. The predicted activity of training and test sets for model 2 is shown in Fig. 5 , it reveals that the model is able to predict the activity of training set quite well as well as an external test set, providing confidence of the model. Result of the actual vs. The predicted inhibitory activity of the training and test set compounds for the Model 1 and 2 is shown in Table 7 . 3D-QSAR: kNN-MFA samples the steric and electrostatic fields surrounding a set of ligands and constructs 3D-QSAR models by correlating these 3D fields with the corresponding biological activities. Molecular alignment was used to visualize the structural diversity in the given set of molecules. The template structure, i.e. para-substituted pyrazolyl-thiazolinone derivatives was used for alignment by considering the common elements of the series as shown in Fig.2 . The statistical significant of 3D-QSAR models are shown in Table 5 set-14,16,18,21,28,33,35,5,6,9 Table 7 represents the predicted inhibitory activity by the model-3 for training and test set. The data fitness plot for model 3 is shown in Fig.7 .The plot of observed vs. The predicted activity provides an idea about how well the model was trained and how well it predicts the activity of the external test set. Result plot in which 3D-alignment of molecules shown in with the important steric and electrostatic points contributing in the model-3 with ranges of values shown in the parenthesis represented in Fig.7 . It shows the relative position and ranges of the corresponding important steric and electrostatic fields in the model provides guidelines for new molecule design as follows- field, S_447 (-0.2808, -0.0321, ) has a negative range indicates that negative steric potential is favorable for an increase in the activity and hence less bulky substituent group is preferred in that region. prove that QSAR equation so obtained is statistically significant and shows the predictive power of the model is 71.85% (internal validation). Table 7 represents the predicted inhibitory activity by the model-4 for training and test set. (d) The data fitness plot for model-4 is shown in Fig. 9 . The plot of observed vs. The predicted activity provides an idea about how well the model was trained and how well it predicts the activity of the external test set. It shows the relative position and ranges of the corresponding important steric and electrostatic fields in the model provides guidelines for new molecule design as follows-(a) Electrostatic field, E_499 (0.3253, 0.3498) has a positive range indicates that positive electrostatic potential is favorable for an increase in the activity and hence the more electronegative substituent group is preferred in that region. (b) Steric field, S_1633 (-0.2808, -0.0302,) has a negative range indicates that negative steric potential is favorable for an increase in the activity and hence more bulky substituent group is preferred in that region. (c) Design and activity prediction of newer derivatives (d) From the best models obtained, some newer compounds were designed claiming to posses better activity than the reported one. The structures were not reported earlier anywhere is confirmed by chem. Spider. Docking studies of newly designed compoundsTo gain a better understanding on the potency of the newly designed compounds (MCR 001-010) we proceeded to examine the interaction of it with EGFR (PDB code: 1M17) by molecular docking, which was performed by simulation of the compound into the ATP binding site in EGFR. The binding model of the compounds and EGFR was depicted in the following figures. The amino acid residues which had interaction with EGFR were labelled. In the binding mode, compound MCR 005 was nicely bound to the ATP binding site of EGFR through hydrophobic interaction and the binding was stabilized by a hydrogen bond and a π-cation interaction. In the binding model, compound MCR 005 was nicely bound to the EGFR kinase with its carbonyl -group of A721 (LYS 721), forming a more optimal hydrogen bond interaction (distance: N-H… O = 2.58A 0 ). Based on the favourable EGFR inhibitory activity of pyrazolyl-thiazolinone derivatives, it could be concluded that this H-bond played an important effect in the EGFR inhibitory. The end amino cation of PHE699A was also formed a π-cation interaction with the benzene ring of the compound MCR 005 (distance: 5.02 A 0 ), which enhanced the binding action between receptor EGFR and the ligand compound MCR 005. The electron donating substituent amino-NH 2 strengthened the π-cation binding and the results indicated that it was primarily due to direct through-space interaction between the subtituent and the cation. Meanwhile, erlotinib was taken as a positive control in the docking procedure. It was found that there was only one sigma-π bond in the binding pocket. The benzene ring of erlotinib formed one sigma-π bond with PHE699A (distance: 3.97 A 0 ). The model between compound MCR 005 and the ATP binding site was similar to that with erlotinib. Comparing these models, it was found that the hydrophobic pockets of ATP binding were all nicely occupied by these compounds, and were nicely occupied by these compounds, and the difference was the combination mode. This molecular docking result, along with the biological assay data, suggesting that the compound MCR 005 was a potential inhibitor of EGFR. Fig.12 Table 7 : Actual and predicted activities for 36 compounds based on the best 2D/3D-QSAR models of para-substituted pyrazolyl-thiazolinone derivatives. 
